LammerEJChenDTHoarRMAgnishNDDenkePJBraunJTRetinoic acid embryopathy. N Engl J Med1985;313:837–41.
2.
RothmanKFPochiPE. Use of oral and topical agents for acne in pregnancy. J Am Acad Dermatol1988;19:431–2.
3.
WorobecSMWongFATolmanELAbramsLSParkerGRThorneEG. Percutaneous absorption of 3H-tretinoin in normal volunteers (abstract). J Invest Dermatol1991;96:574A.
4.
JickSSTerrisBZJickH. First trimester topical tretinoin and congenital disorders. Lancet1993;341:1181–2.
5.
FrantzTJLehmanPA. Systemic absorption of retinoic acid. J Toxicol Cutan Ocul1990;9:517–24.
6.
KawashimaHOhnoIUenoYNakayaSKaloETaniguchiN. Syndrome of microtia and aortic arch anomalies resembling isotretinoin embryopathy. J Pediatr1987;111:738–40.
7.
KwasigrochTEBullenM. Effects of isotretinoin (13-cis-retinoic acid) on the development of mouse limbs in vivo and in vitro. Teratology1991;44:605–16.
8.
CameraGPregliascoP. Ear malformation in baby born to mother using tretinoin cream (letter). Lancet1992;339:687.
9.
LipsonAHCollinsFWebsterWS. Multiple congenital defects associated with maternal use of topical tretinoin. Lancet1993;341:1352–3.
